Współczesna Onkologia

Full text

3/2026 vol. 30
Original paper

Surgical treatment of retroperitoneal sarcomas: analysis of multi-organ resections and factors influencing perioperative outcomes

Jacek Maciej Skoczylas 1
,
Iwona Kalinowska 1
,
Konrad Zaborowski 1
,
Marcin Zdzienicki 1
,
Andrzej Pieńkowski 1
,
Piotr Błoński 2
,
Paweł Michalak 3
,
Pawel Teterycz 1
,
Piotr Rutkowski 1

  1. Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

  2. Doctoral School of Molecular Medicine, Medical University of Lodz, Lodz, Poland

  3. Faculty of Medicine, Warsaw Medical University, Warsaw, Poland

Contemp Oncol (Pozn) 2026; 30 (3): 249–254

DOI: https://doi.org/10.5114/wo.2026.166046
Data publikacji online: 2026/11/09
Article file
Surgical treatment.pdf
  1. Burningham Z, Hashibe M, Spector L, Schiffman JD. The epidemiology of sarcoma. Clin Sarcoma Res 2012; 2: 14.
  2. Tseng WW, Seo HJ, Pollock RE, Gronchi A. Historical perspectives and future directions in the surgical management of retroperitoneal sarcoma. J Surg Oncol 2018; 117: 7-11.
  3. Wang J, Grignol VP, Gronchi A, Luo CH, Pollock RE, Tseng WW. Surgical management of retroperitoneal sarcoma and opportunities for global collaboration. Chin Clin Oncol 2018; 7: 39.
  4. Swallow CJ, Strauss DC, Bonvalot S, Rutkowski P, Desai A, Glad- dy RA, et al. Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the Transatlantic Australasian RPS Working Group. Ann Surg Oncol 2021; 28: 7873-7888.
  5. Rutkowski P, Bonvalot S. New roads in retroperitoneal sarcomas. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 2023; 49: 1051-1052.
  6. Gronchi A, Lo Vullo S, Fiore M, Mussi C, Stacchiotti S, Collini P, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol Off J Am Soc Clin Oncol 2009; 27: 24-30.
  7. Bonvalot S, Rivoire M, Castaing M, Stoeckle E, Le Cesne A, Blay JY, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol Off J Am Soc Clin Oncol 2009; 27: 31-37.
  8. Dominguez DA, Sampath S, Agulnik M, Liang Y, Nguyen B, Trisal V, et al. Surgical management of retroperitoneal sarcoma. Curr Oncol 2023; 30: 4618-4631.
  9. Zhang J, Deng K, Zheng Y, Ban B, Li G, Lian J, et al. Global trends in retroperitoneal sarcomas surgery: a bibliometric analysis from 2005 to 2024. Discov Oncol 2025; 16: 1827.
  10. Improta L, Pasquali S, Iadecola S, Barisella M, Fiore M, Radaelli S, et al. Organ infiltration and patient risk after multivisceral surgery for primary retroperitoneal liposarcomas. Ann Surg Oncol 2023; 30: 4500-4510.
  11. Bonvalot S, Miceli R, Berselli M, Causeret S, Colombo C, Mariani L, et al. Aggressive surgery for retroperitoneal soft tissue sarcoma performed at high-volume centers is safe and associated with improved local control. Ann Surg Oncol 2010; 17: 1507-1514.
  12. Pisters PWT. Resection of some – but not all – clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol Off J Am Soc Clin Oncol 2009; 27: 6-8.
  13. MacNeill AJ, Fiore M. Surgical morbidity in retroperitoneal sarcoma resection. J Surg Oncol 2018; 117: 56-61.
  14. Munoz P, Bretcha-Boix P, Artigas V, Asencio JM. Surgical principles of primary retroperitoneal sarcoma in the era of personalized treatment: a review of the frontline extended surgery. Cancers 2022; 14: 4091.
  15. Purgina B, Di Blasi E, Collini P, Dei Tos AP, Fiore M, Gronchi A, et al. Pathologic assessment of retroperitoneal sarcomas: a position paper by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Am J Surg Pathol 2026; 50: 455-466.
  16. Gorji L, Nikahd M, Onuma A, Tsilimigras D, Hyer JM, Ruff S, et al. Comparing multivisceral resection with tumor-only resection of liposarcoma using the win ratio. Ann Surg Oncol 2024; 31: 3389-3396.
  17. Ruff SM, Grignol VP, Contreras CM, Pollock RE, Beane JD. Morbidity and mortality after surgery for retroperitoneal sarcoma. Curr Oncol 2022; 30: 492-505.
  18. Adam MA, Moris D, Behren S, Nussbaum DP, Jawitz O, Turner M, et al. Hospital volume threshold for the treatment of retroperitoneal sarcoma. Anticancer Res 2019; 39: 2007-2014.
  19. Fan P, Tao P, Wang Z, Wang J, Lu W, Ma L, et al. The evolution of surgical strategies for retroperitoneal sarcoma (RPS): time-trend and outcome analysis from 878 consecutive resections in an Asian high-volume sarcoma center. Curr Probl Surg 2025; 73: 101924.
  20. Fairweather M, Wang J, Jo VY, Baldini EH, Bertagnolli MM, Raut CP. Surgical management of primary retroperitoneal sarcomas: rationale for selective organ resection. Ann Surg Oncol 2018; 25: 98-106.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Coverage in
Indexed in
pubmed
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications